BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang D, Lin T, Wang S, Cheng L, Xie L, Lu Y, Chen M, Zhu L, Shi J. The liver fibrosis index is superior to the APRI and FIB-4 for predicting liver fibrosis in chronic hepatitis B patients in China. BMC Infect Dis 2019;19:878. [PMID: 31640590 DOI: 10.1186/s12879-019-4459-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Chadha N, Sterling RK. Noninvasive Tests for Liver Fibrosis in Chronic Hepatitis B Virus. Curr Hepatology Rep 2022;21:68-75. [DOI: 10.1007/s11901-022-00592-2] [Reference Citation Analysis]
2 Gabr AK, Hawash NI, Abd-elsalam S, Badawi R, Soliman HH. Diagnostic Accuracy of Red Cell Distribution Width to Platelet Ratio for Detection of Liver Fibrosis Compared with Fibroscan in Chronic Hepatitis B Egyptian patients. TOBIOMJ 2022;12. [DOI: 10.2174/18753183-v12-e2208150] [Reference Citation Analysis]
3 Ding R, Zhou X, Huang D, Wang Y, Li X, Yan L, Lu W, Yang Z, Zhang Z. Nomogram for predicting advanced liver fibrosis and cirrhosis in patients with chronic liver disease. BMC Gastroenterol 2021;21:190. [PMID: 33906623 DOI: 10.1186/s12876-021-01774-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Wang J, Zhang P, Liao J, Zhu Y, Liu X, Tang H. Association of α-fetoprotein levels with liver stiffness measurement in outpatients with chronic hepatitis B. Biosci Rep 2021;41:BSR20203048. [PMID: 33289529 DOI: 10.1042/BSR20203048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Guvenir M, Arikan A. Hepatitis B Virus: From Diagnosis to Treatment. Pol J Microbiol 2020;69:391-9. [PMID: 33574867 DOI: 10.33073/pjm-2020-044] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
6 Mohamed AA, Hemeda AA, Aziz RK, Abdel-hakeem MS, Ali-tammam M. Body mass index (BMI) and alpha-fetoprotein (AFP) level correlate with the severity of HCV-induced fibrosis in a cohort of Egyptian patients with chronic HCV. Futur J Pharm Sci 2020;6:71. [DOI: 10.1186/s43094-020-00085-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Zhu Y, Qiao M, Yang J, Hu J. Elucidating the Mechanisms of Hugan Buzure Granule in the Treatment of Liver Fibrosis via Network Pharmacology. Evidence-Based Complementary and Alternative Medicine 2020;2020:1-11. [DOI: 10.1155/2020/8385706] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Wu J, Mao W. Review of Serum Biomarkers and Models Derived from Them in HBV-Related Liver Diseases. Dis Markers 2020;2020:2471252. [PMID: 32774512 DOI: 10.1155/2020/2471252] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Huang M, Lu X, Wang X, Shu J. Diffusion tensor imaging quantifying the severity of chronic hepatitis in rats. BMC Med Imaging 2020;20:74. [PMID: 32615932 DOI: 10.1186/s12880-020-00466-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Qiao M, Yang J, Zhao Y, Zhu Y, Wang X, Wang X, Hu J. Antiliver Fibrosis Screening of Active Ingredients from Apium graveolens L. Seeds via GC-TOF-MS and UHPLC-MS/MS. Evid Based Complement Alternat Med 2020;2020:8321732. [PMID: 32148553 DOI: 10.1155/2020/8321732] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]